A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis—in some ...

Metformin may offer more than blood sugar support for women over 50. The article says it can aid weight loss and may support sharper vision, heart health, and longevity. It also notes a lower cancer ...

Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...

The search space is the set of all complete 81-cell assignments, not partial states. Cost function / fitness: count the number of constraint violations. Goal: minimize violations to 0. This reframing ...

It was mid-October, peak leaf-peeping season in Hanover, New Hampshire, and Chad Markey was on a rare break between clinical rotations during his last year of medical school. He should have been ...

A new therapy for genetic hearing loss has just been approved by the Food and Drug Administration (FDA). The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated ...

What Is Otarmeni, and Why Does It Matter? Otarmeni (lunsotogene parvec-cwha) is a single-use gene therapy for children and adults who have severe or profound hearing loss (a hearing level of more than ...

There have been many travel disruptions so far in 2026. They include events such as the war in Iran, military operation in Venezuela, cartel violence in Mexico, an East Coast blizzard and the ongoing ...

In the months following Elon Musk’s $44 billion acquisition of Twitter in 2022, my experience with the platform (and perhaps yours too) got quickly, dramatically worse. My algorithmic timeline, better ...

The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across the entire tree of life, Evo 2 can identify patterns in gene sequences across ...

Mediterranean restaurant chain Cava beat Wall Street estimates for its fourth-quarter earnings and forecast growth for fiscal year 2026. The company reported full-year revenue of more than $1 billion ...